NaCl solution

DRUG5 trials

Sponsors

Queen's University, GlaxoSmithKline Biologicals, Nuvo Research GmbH, Guangdong Provincial People's Hospital, University of Edinburgh

Conditions

Allergic RhinitisCOVIDCarcinoma, HepatocellularHerpes SimplexSeverely burned patientsUpper Respiratory Tract InfectionsVirusVirus Diseases

Phase 1

A Phase I/II, observer-blind, randomised, placebo-controlled, multi-country study to evaluate reactogenicity, safety, immune response, and efficacy of an HSV-targeted immunotherapy in healthy participants aged 18-40 years or in participants aged 18-60 years with recurrent genital herpes.

CompletedCTIS2024-510571-37-00

GlaxoSmithKline BiologicalsHerpes Simplex

Start: 2023-12-06End: 2025-04-10Target: 407Updated: 2025-05-27

Phase 2

PILOT STUDY OF THE EFFICACY AND SAFETY OF WF10 IN SUBJECTS SUFFERING FROM PERSISTENT ALLERGIC RHINITIS

CompletedNCT01586468

Nuvo Research GmbHAllergic Rhinitis

Start: 2010-03-31End: 2010-11-30Updated: 2012-04-26

Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma

Guangdong Provincial People's HospitalCarcinoma, Hepatocellular

Start: 2013-06-30End: 2016-12-31Target: 258Updated: 2013-06-05

VItamin C in Thermal injuRY: The VICToRY Trial A phase III multi-center randomized trial

Active, not recruitingCTIS2023-504772-21-00

Queen's UniversitySeverely burned patients

Start: 2022-11-22Target: 339Updated: 2025-02-04

Unknown Phase

Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19)

TerminatedNCT04382131

University of EdinburghCOVID, Upper Respiratory Tract Infections, Virus +2

Start: 2020-06-23End: 2020-10-31Updated: 2026-03-03